Citius Pharma
2007
FOUNDED
PUBLIC
STATUS
1-10
EMPLOYEES
CTXR
STOCK SYMBOL
2
INVESTMENTS
$1.08
SHARE PRICE
(As of Tuesday Closing)
Description
Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the development and commercialization of anti-infective products, adjunctive cancer care, and unique prescription products. Citius is currently advancing two proprietary product candidates, Mino-Lok product and a Hydrocortisone-Lidocaine formulation. Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company's Hydrocortisone-Lidocaine provides anti-inflammatory and anesthetic relief to patients suffering from Grade I and II hemorrhoids. The company is primarily operating within the critical care and cancer care market segments.
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
- 11 Commerce Drive
- 1st Floor
- Cranford, NJ 07016
- United States
+1 (908) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Citius Pharma’s full profile, request a free trial.
Citius Pharma Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $0.86 - $2.52 | $23.8M | $1.11 | -$0.79 | 90.7K | 22.1M |
Citius Pharma Financials Summary
|
In Thousands,
USD |
TTM
30-Jun-2019
|
FY 2018
30-Sep-2018
|
FY 2017
30-Sep-2017
|
FY 2016
30-Sep-2016
|
|---|---|---|---|---|
| Enterprise Value | 18,608 | 25,111 | 31,235 | 44,561 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (14,783) | (12,519) | (9,532) | (8,286) |
| Net Income | (14,759) | (12,537) | (10,385) | (8,296) |
| Total Assets | 25,545 | 31,051 | 24,417 | 21,950 |
| Total Debt | 173 | 173 | 173 | 673 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Citius Pharma Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Citius Pharma‘s full profile, request access.
Request full access to PitchBookCitius Pharma Competitors (46)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Recro Pharma | Corporation | Malvern, PA | 000 | 00000 | 000000000 | 00000 |
| 000 000000 | Private Equity-Backed | Farmville, NC | 000.00 | 000000000 | 000.00 | |
| 00000 | Corporate Backed or Acquired | Mumbai, India | 00000 | 00000000 | ||
| 000 00000 | Corporation | Indianapolis, IN | 00000 | 0000 | ||
| 000000 | Venture Capital-Backed | San Francisco, CA | 0 | 0000 | 000000000000 | 0000 |
Citius Pharma Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000-00000 0000 | 04-Apr-2016 | 000000000000000000 | Biotechnology | 0000000 00000 | |
| Trail One | 12-Sep-2014 | Merger/Acquisition | 00.000 | Other Consumer Products and Services |
Citius Pharma Executive Team (8)
3 Former Executives
You’re viewing 5 of 8 executives. Get the full list »Citius Pharma Board Members (8)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Carol Webb | Citius Pharma | Board Member | 000 0000 | |
| Eugene Holuka MD | Citius Pharma | Board Member | 000 0000 | |
| Howard Safir | Citius Pharma | Board Member | 000 0000 | |
| Leonard Mazur | Self | Chairman & Board Member | 000 0000 | |
| Myron Holubiak | Citius Pharma | Chief Executive Officer & Board Member | 000 0000 |
1 Former Board Member
You’re viewing 5 of 8 board members. Get the full list »